Clinical trial

Islet Transplantation in Type 1 Diabetes

NCT00434811

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-10-01

PhasePHASE3

Study timeline

Study start (unknown)2006-10-01Date precision: month

Registry last updated2019-07-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetes Mellitusverified · MONDO: type 1 diabetes mellitus

Interventions

Allogeneic Pancreatic Islet CellsBIOLOGICAL

Antithymocyte GlobulinBIOLOGICAL

SirolimusDRUG · verified · RxNorm: sirolimus

TacrolimusDRUG · verified · RxNorm: tacrolimus

EtanerceptBIOLOGICAL

Islet TransplantationPROCEDURE

BasiliximabBIOLOGICAL

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

ChicagoIllinois, United States2 PhiladelphiaPennsylvania, United States1 AtlantaGeorgia, United States1 MiamiFlorida, United States1 San FranciscoCalifornia, United States1 MinneapolisMinnesota, United States1 EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00434811 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.